Abstract
The level of an endogenous opioid (peak B endorphin) was measured in chromatographically fractionated cerebrospinal fluid (CSF) sampled from two groups of chronic pain patients before and after intrathecal saline (placebo) injection. As assessed by a verbal rating scale, one group reported no change in their level of pain (non-responders, NR;n=6) while the other group reported complete or >50% pain relief (placebo responders, PR;n=14). We find, as has been reported previously, that initial peak B levels were lower (by 50%) in these chronic pain patients' CSF than in CSF from pain-free (PF) normal controls (P<0.001,t-test). Peak B levels measured from CSF of the NR group undergoing this procedure did not change (P>0.4, pairedt-test). In contrast, a significant 2.3-fold increase was measured in the CSF peak B level of the PR group (P<0.05, pairedt-test). This is the first direct evidence that a CSF opioid is correlated with placebo pain relief in chronic pain patients. Peak B is a potent analgesic substance when administered by the intracerebroventricular route in mice and its level is related to the patients' pain status in a presumably causal manner.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahlgren EW, Stephen CR, Lloyd EAC, McCollum DE (1966) Diagnosis of pain with a graduated spinal block technique. JAMA 195:813–816
Akil H, Richardson DE, Hughes J, Barchas J (1978) Enkephalinlike material elevated in ventricular CIF of pain patients after analgetic focal stimulation. Science 201:463–465
Almay BG, Johansson E, Von Knorring O, Terenius L, Wahlstrom A (1978) Endorphins in chronic pain I: differences in CSF endorphin levels between organic and psychogenic pain syndromes. Pain 5:153–162
Basbaum AI, Fields HL (1984) Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 7:309–338
Beecher HK (1955) The powerful placebo. JAMA 159:1602–1606
Brena SF, Wolf SL, Chapman SL, Hammonds WD (1980) Chronic back pain: electromyographic, motion and behavioral assessments following sympathetic nerve blocks and placebos. Pain 8:1–10
Buchsbaum MS, Davis GC, Naber D, Pickar D (1983) Pain enhances naloxone-induced hyperalgesia in humans as assessed by somatosensory evoked potentials. Psychopharmacology 79:99–103
Dehen H, Willer JC, Prier S, Boureau F, Cambier J (1978) Congenital insensitivity to pain and the “morphine-like” analgesia syndrome. Pain 5:351–358
Dewey WL, Bowman E, Jones D, Kachur J, Rosemond R, Welch S, Martin BR (1982) The appearance of endogenous opiates in cerebrospinal fluid following opiate injection in various animal species. Life Sci 31:1741–1743
Evans FJ (1974) The power of the sugar pill. Psychol Today 7:55–59
Fabbri A, Fraioli F, Cruccu G, Manfredi M, Pert C, Pert A (1984) Intracerebral injection of CSF from a patient with congenital indifference to pain induces analgesia in rats. Experientia 40:1365–1366
Gracely RH, Dubner R, Wolskee PJ, Deeter WR (1983) Placebo and naloxone can alter post-srugical pain by separate mechanisms. Nature 306:264–265
Grevert P, Albert LH, Goldstein A (1983) Partial antagonism of placebo analgesia by naloxone. Pain 16:129–143
Hargreaves KM, Dionne RA, Mueller PG, Golstein DS, Dubner R (1986) Naloxone, fentanyl and diazepam modify plasma betaendorphin levels during surgery. Clin Pharmacol Ther 40:165–171
Hayes RL, Price DD, Bennett GJ, Wilcox GL, Mayer DJ (1978) Differential effects of spinal cord lesions on narcotic and non-narcotic suppression of the nociceptive reflexes. Brain Res 155:91–101
Jungkunz G, Engel RR, King UG, Kuss HJ (1983) Endogenous opiates increase pain tolerance after stress in humans. Psychiatry Res 8:13–18
Lasagna L, Mosteller F, Von Felsinger JM, Beecher HK (1954) A study of the placebo response. Am J Med 16:770–779
Levine JD, Gordon NC, Fields HL (1978a) The mechanism of placebo analgesia. Lancet II:657–754
Levine JD, Gordon NC, Fields HL (1978b) Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain. Nature 278:741–742
Levine JD, Gordon NC, Bornstein JC, Fields HL (1979) Role of pain in placebo analgesia. Proc Natl Acad Sci 76:3528–3531
Levine JD, Gordon NC (1986) Method of administration determines the effect of naloxone on pain. Brain Res 365:377–378
Lipman JJ, Miller BE, Mays KS, North WC, Karara S, Byrne WL (1981) CSF Endorphin levels in chronic pain patients before and after a placebo pain relief. Endogenous and exogenous opiate agonists and antagonists. Kodansha Press, Tokyo, Japan, pp 315–317
McCollum DE, Stephen CR (1964) The use of graduated spinal anesthesia in the differential diagnosis of pain the back and lower extremities. South Med J 57:410–416
Miller BE, Lipman JJ, Byrne WL (1987) Partial characterization of a novel endogenous opioid in human cerebrospinal fluid. Life Sci 41:2535–2545
Posner J, Burke CA (1985) The effects of naloxone on opiate and placebo analgesia in healthy volunteers. Psychopharmacology 87:468–472
Puig M, Laorder M, Miralles F, Olaso M (1982) Endorphin levels in CSF of patients with postoperative and chronic pain. Anesthesiology 57:1–4
Sarnoff SJ, Arrowood JG (1946) Differential spinal block. Surgery 20:150–165
Sjolund B, Terenius L, Erikson M (1977) Increased cerebrospinal fluid levels of endorphins after electroacupuncture. Acta Physiol Scand 100:382–384
Spiegel D, Albert LH (1983) Naloxone fails to reverse hypnotic alleviation of chronic pain. Psychopharmacology 81:140–143
Stimmell B (1983) Neuroregulators and pain. Pain, analgesia and addiction. Raven Press, New York, pp 18–38
Teeple E, Scott DL, Ghia JN (1982) Intrathecal normal saline without preservative does not have a local anethetic effect. Pain 14:3–10
Terenius L (1978) The implications of endorphins in pathological states. In: Van Ree JM, Terenius L (eds) Characteristics and functions of opioids. Elsevier, Amsterdam, pp 143–157
Terenius L, Wahlstrom A (1975) Morphine-like ligand for opiate receptors in human CSF. Life Sci 16:1759–1764
Urban BJ, McKain CW (1978) Local anesthetic effect of normal saline. Pain 5:43–52
Willer JC, Albe-Fessard D (1980) Electrophysiological evidence for a release of endogenous opiates in stress-induced analgesia in man. Brain Res 198:419–426
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lipman, J.J., Miller, B.E., Mays, K.S. et al. Peak B endorphin concentration in cerebrospinal fluid: reduced in chronic pain patients and increased during the placebo response. Psychopharmacology 102, 112–116 (1990). https://doi.org/10.1007/BF02245754
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245754